Chapter 1. Research Objective
1.1 Objective, Definition & Scope
1.2 Methodology
1.2.1 Primary Research
1.2.2 Secondary Research
1.2.3 Market Forecast - Estimation & Approach
1.2.4 Assumptions & Assessments
1.3 Insights and Growth - Relevancy Mapping
1.3.1 FABRIC Platform
1.4 Data mining & efficiency
Chapter 2. Executive Summary
2.1 Transplant Diagnostics Market Overview
2.2 Interconnectivity & Related markets
2.3 Ecosystem Map
2.4 Transplant Diagnostics Market Business Segmentation
2.5 Transplant Diagnostics Market Geographic Segmentation
2.6 Competition Outlook
2.7 Key Statistics
Chapter 3. Strategic Analysis
3.1 Transplant Diagnostics Market Revenue Opportunities
3.2 Cost Optimization
3.3 Covid19 aftermath - Analyst view
3.4 Transplant Diagnostics Market Digital Transformation
Chapter 4. Market Dynamics
4.1 DROC
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PEST Analysis
4.2.1 Political
4.2.2 Economic
4.2.3 Social
4.2.4 Technological
4.3 Market Impacting Trends
4.3.1 Positive Impact Trends
4.3.2 Adverse Impact Trends
4.4 Porter's 5-force Analysis
4.5 Market News - By Segments
4.5.1 Organic News
4.5.2 Inorganic News
Chapter 5. Market Segmentation
The Transplant Diagnostics Market has been analysed to include the below segmentation:
By Products
• Reagents & Consumables
• Instruments & Software
By Applications
• Applications
• Diagnostic Applications
• Research Applications
By Transplantation
• Solid Organ
Transplantation
• Soft Tissue
Transplantation
By Technology
• Molecular
• Non-molecular
Chapter 5A. Regional Segmentation
The Transplant Diagnostics Market has been analysed by studying the following regions:
North America
• By Products
• By Applications
• By Transplantation
• By Technology
Europe
• By Products
• By Applications
• By Transplantation
• By Technology
APAC
• By Products
• By Applications
• By Transplantation
• By Technology
LatAm
• By Products
• By Applications
• By Transplantation
• By Technology
MEA
• By Products
• By Applications
• By Transplantation
• By Technology
**The Regions are further studied to analyse the major countries within the respective regions. The coverage of the country level data is dynamic and is updated regularly based on the market movements. Normally, the countries covered in the report include:
• North America - United States, Canada, Mexico;
• Europe - United Kingdom, France, Italy, Germany, Spain, Rest of Europe;
• Asia Pacific - China, India, Japan, South Korea, Rest of APAC;
• Middle East & Africa - South Africa, GCC Countries, Rest of MEA;
• Latin America - Brazil, Argentina, Rest of LatAm;
Chapter 6. Market Use case studies
Chapter 7. KOL Recommendations
Chapter 8. Investment Landscape
8.1 Transplant Diagnostics Market Investment Analysis
8.2 Market M&A
8.3 Market Fund Raise & Other activity
Chapter 9. Transplant Diagnostics Market - Competitive Intelligence
9.1 Company Positioning Analysis
9.1.1 Positioning - By Revenue
9.1.2 Positioning - By Business Score
9.1.3 Legacy Positioning
9.2 Competitive Strategy Analysis
9.2.1 Organic Strategies
9.2.2 Inorganic Strategies
Chapter 10. Key Company Profiles
*The Transplant Diagnostics Market Report profiles companies based on the material impact they have on the market ecosystem. These are hence, to be read as 'Key Players' and not necessarily 'Market Leaders'.
Companies are typically profiled to include:
10.x.1 Company Fundamentals
10.x.2 Performance Overview
10.x.3 Product Overview
10.x.4 Recent Developments
Key Companies profiled in this report include:
• THERMO FISHER SCIENTIFIC
• F HOFFMANN-LA ROCHE
• BIOM•RIEUX
• BIO-RAD LABORATORIES
• QIAGEN
• IMMUCOR
• CAREDX
• ELITECHGROUP
Chapter 11. Appendix
11.1 About AllTheResearch (ATR)
11.2 ATR Services
11.3 Author details
11.4 Terms & Conditions
11.5 Contact us